INTRODUCTION
The provision of health care services now constitutes one of the largest industries in OECD countries. The impact of this sector is evidenced by the widespread public interest in the constant flow of new innovations reported in the media.
Near-universal coverage of the population under public and private health plans has been achieved in most OECD countries, and there have been impressive gains in the health status of populations in all of these countries.
T h e re remain, however, re c u rrent conc e rns re g a rding the adequacy of re s o u rc e s ; the way they are used; and how best to increase the equity, efficiency, and effectiveness of health care. After a decade or more of health care reform, the question of how best to organize health care and its financing remains high on the political agenda in many OECD countries.
To assist health care policymakers and re s e a rchers with inter national comparisons, the OECD Secretariat publishes an annual information system on CD-ROM, OECD Health Data ( O rganization for Economic Cooperation and Development, 1999a) . This covers data on key aspects of health care systems in the 29 OECD member countries and their general demographic, economic, and social contexts (Organization for Economic Cooperation and Development, 1999a; Anderson and Poullier, 1999) .
In this article, I provide an overview and basic analysis of the health accounts collected annually by the OECD Secretariat. This updates and complements some of the earlier synthesis and research on this subject (Organization for Economic Cooperation and Development, 1995, 1993; Schieber, Poullier, and Greenwald, 1994) and previous presentations in this journal (Schieber, Poullier, and Greenwald, 1992) . Levels of and trends in health expenditures are compared in absolute terms and relative to overall economic growth. The d e t e rminants of health care spending growth are revisited.
Progress in the international comparability of health expenditure estimates depends heavily on the quality and detail of national health accounts in OECD member countries.
Although decisive pro g ress in health accounting has been made in several countries over the last 5 years, much research and statistical work remains to be done to make health accounts more comprehen-sive and comparable across countries. Serious gaps remain in the scope of the data, and problems remain in the comparability of the data across countries. A short overview of recent progress in the methodology of the OECD health accounts and reports on revisions to the expenditure estimates appears later in this article.
1990-1997 TRENDS RELATIVE TO GDP
After many years in which health expenditures grew faster than the economy, in 1997, the United States spent about the same proportion of its gross domestic product (GDP) on health care as in 1992. The trend in this expenditure ratio in the United States is thus for the first time parallel to the average across 25 OECD countries, for which long time series are available ( Figure 1 and Table 1) (Organization  for  Economic  Cooperation and Development, 1999d) .
In 1997, the United States spent approximately 90 percent more on health care as a share of GDP than in 1970. Health expenditures thus increased at a faster pace in the United States than in other OECD countries, which on average are now spending a 60-percent greater share of their GDP on health care than in 1970. In several OECD countries, modest declines during the 1990s were related both to economic upswings in countries and to reforms that have limited the rate of increase in health spending in relation to the rate of growth in GDP (Organization for Economic Cooperation and Development, 1999b 1970 1972 1974 1976 1978 1986 1984 1982 1980 1988 1990 1992 1994 The United States is now among a group of countries in which the percentage of GDP devoted to health care has stabilized or declined slightly since the early-to-mid1990s. This gives rise to the question of whether such stabilization can be sustained or is a transitory phenomenon.
A full listing of the factors that account for growth in health expenditures-both in absolute terms and relative to overall economic development-would re q u i re a detailed analysis per country, which is not the subject of this article. Here, I concentrate on international comparisons, which draw mainly on lessons learned from the latest version of the comparative data sets of OECD Health Data 99 (Organization for Economic Cooperation and Development, 1999a ).
An immediate question to ask is whether the stabilization of expenditure trends over the last couple of years is due mainly to an upswing in the business cycle in many countries. To analyze this question, an alternative expenditure ratio was calculated, which divides health expenditures by trended GDP instead of current GDP and is somewhat smoother than and more independent of the business cycle. Table 2 shows that there are clear signs of a real stabilization of the growth of health spending in relation to trend GDP. An Figure 2 and Table 3 show that countries differ less in terms of expenditure ratios than per capita expenditures. The United States still spends far more per capita on health care than any other OECD country, outspending Canada on an average per capita basis by 2 to 1, Japan by 2.3 to 1, and all other OECD countries by 2.5 to 1. U.S. health care spending per capita was $4,095 in 1997, compared with an average of $1,615 (calculated on a U.S. dollar GDP purchasing power parity [PPP] basis) for the OECD as a whole and $1,698 in the European Union. Switzerland had the second-highest spending per capita, followed by Germany, Luxembourg, and Canada.
T h e re are two main reasons why countries differ less in terms of expenditure ratios than in per capita expenditures. First, t h e re seems to be some correlation between low health expenditure ratios and lower per Figure 2 . However, overall, GDP PPPs differ substantially from health sector PPPs for many countries. Figure 3 shows that per capita expenditures calculated using health sector PPPs vary less across countries. For the United States, this means that the difference in per capita expenditures between the United States and all other OECD countries is largely the result of higher relative prices for health care in the United States (Gerdtham and Jönsson, 1991; Evans, 1998) .
Unfortunately, price comparisons and PPPs for health care goods and services are among the weak points in international health care data sets. Health-specific PPPs and hence the results shown in Figure 3 should therefore be used with caution.
CONVERGENCE OR DIVERGENCE OF EXPENDITURE PATTERNS?
A well-known observation is that growing wealth is associated with higher per capita health spending both over time and across countries. The most frequent illustration of this fact is provided in Figure 4 , which compares per capita health spending with per capita GDP figures for the year 1997. b o u r g C a n a d a F r a n c e D e n m a r k N o r w a y I c e l a n d N e t h e r l a n d s A u s t r a l i a A u s t r i a B e l g i u m S w e d e n F i n l a n d N e w Z e a l a n d I r e l a n d G r e e c e S p a i n P o r t u g a l C z e c h R e p u b l i c K o r e a H u n g a r y M e x i c o P o l a n d F i g u re 4 suggests that OECD countries fall into three broad clusters according to income class: countries with annual per capita incomes of US$20,000 and less; those with average incomes between US$20,000 and US$30,000; and the two countries with the highest incomes, the United States and L u x e m b o u rg, which are apparent outliers f rom the linear re l a t i o n s h i p .
The association between income and health expenditure seems to be much stronger for the first cluster than for the remaining countries, for which similar income levels are associated with substantially different health expenditure levels.
As an illustration: Split into two groups at the US$20,000 level, a regression for the first lower income group shows an R 2 measure that is more than twice as high as that of the second group: 0. Of the second group, all but one of the Scandinavian countries lie below the trend lines, as do Japan, Ireland, and the United Kingdom. Germany, France, and Switzerland are the three countries spending considerably more than what would be expected from the trend line in Figure 4 .
Health care spending in Germany is relatively high compared with its per capita GDP mainly because health care spending in the 5 eastern and 11 western States have converged much faster after reunification than did overall economic productivity. Sweden, the Netherlands, and Canada are all close to or on the trend line.
The slope of the trend line and the R 2 vary over time with individual countries moving closer to or further away from the trend line (Schieber, Poullier, and Greenwald, 1992) . Hints on specific developments in individual countries are provided by Figure 5 , which illustrates the way in which some countries have converged with and other countries have diverged from the OECD trend. Arrows show the movement of countries away from and toward the common trend shown by the combined sample of both years.
As has been noted in previous analysis for various time periods, the United States moved further away from the common trend of other OECD countries in the years before 1993, the year after which the United States spending ratio stabilized. Other diverging countries are Germany (because of the economic shock of reunification as already mentioned), Switzerland, and Luxembourg. In several countries, such as Greece, Canada, and the United Kingdom, health expenditures grew paral- I c e l a n d A u s t r a l i a N e t h e r l a n d s A u s t r i a B e l g i u m S w e d e n F i n l a n d N e w Z e a l a n d I r e l a n d G r e e c e S p a i n P o r t u g a l lel to the overall trend. Some Scandinavian countries, such as Denmark and Norway, seem to have been more successful with cost-containment measures than other OECD countries.
CONTINUING STABILIZATION IN 1998
Will the stabilization of health expenditure trends, observed recently in a majority of OECD countries, continue into the near future? The answer to this question is of interest not only to policymakers and health care planners but also to the whole range of suppliers of health care services and goods. And it increasingly interests the broad public, which has a growing awareness that cost-containment measures applied to health care under public budgets may affect access to services, coverage under public programs, and copayment levels. Table 4 provides a synthesis of some current projections for the year 1998 and/or preliminary health expenditure estimates for a selection of OECD countries together with preliminary GDP figures. Sources and methods for these estimates can be found in OECD Health Data (Organization for Economic Cooperation and Development, 1999b) .
Expenditure ratios tend to remain relatively stable or increase slightly for the countries analyzed in Table 4 . For Japan and New Zealand, expenditure ratios are estimated to increase mainly because of low or negative growth of the national economy compared with moderate increases in health expenditure. 
DECOMPOSITION OF HEALTH EXPENDITURE GROWTH
The decomposition of health expenditure growth into price and volume components is used on a regular basis in many countries for projections of national health expenditures. A similar approach, applied to a cross-section comparison of expenditure growth across countries, helps to identify which growth elements underlie the marked increase of health expenditure ratios relative to GDP in past years. For these decompositions, readers should be aware that price and volume measurement is an extremely difficult task for health care services. International comparisons of trends of expenditure in real terms should consequently be used with caution. This section provides an update of the basic model developed for this purpose. (For more details on the underlying mathematics, refer to Schieber and Poullier, 1989, and Schieber, Poullier, and Greenwald, 1992.) Estimates of the relative magnitude of the growth elements are shown in Table 5 for 16 OECD countries. A comparison of these calculations for 1980-1996 reveals surprisingly similar results to tables published earlier.
From 1980 to 1996, increases in the health care price deflator were higher than those of the GDP deflator in 12 of the 16 countries under study. The growth of the volume of real health care services per capita surpassed overall income growth in only 11 countries during the same period.
In times when health expenditures grow faster than the overall economy, one of the following conditions must hold true: • Health care prices grow faster than general GDP inflation.
• The volume of health care services per capita increases faster than overall economic growth per capita (measured as real GDP per capita). Table 5 shows the excess of health care inflation over GDP inflation and the excess growth in the volume of health care over growth in the volume of GDP per capita. These calculations show that the excess of health care inflation over the GDP deflator was the dominating factor accounting for rising health expenditure ratios in the past. The United States not only spends a higher share of GDP on health care than all other countries under study but has also experienced the fastest divergence between the growth paths of health expenditures and GDP.
HEALTH CARE FINANCING REVIEW/Winter 1999/Volume
The excess volume growth of real health expenditures per capita over real GDP per capita accounts for less than 20 percent of the growth of nominal health expenditures relative to nominal GDP. In the United States, the difference between the growth rates of nominal health expenditures and nominal GDP was on average 2.7 percent per year for the period 1980-1996. Roughly 2.2 percent of this difference was due to excess health care inflation. Excess per capita volume growth was only 0.6 percent on average during this time period.
Countries are ranked in Figure 6 according to their divergence between the growth path in health expenditures and GDP. The divergence is broken down into excess health care inflation and excess health care volume growth over real income growth.
TRENDS IN HEALTH CARE FINANCING
There are large differences in the way health care services are funded in OECD countries. I c e l a n d S w e d e n J a p a n S p a i n G e r m a n y N e w Z e a l a n d F i n l a n d I r e l a n d F r a n c e A u s t r i a S w i t z e r l a n d A u s t r a l i a U n i t e d S t a t e s K o r e a P o r t u g a l C a n a d a I t a l y of total health spending into main sources of funding; this information was collected as part of the current revisions and amendments to OECD health accounts. The 20 countries for which comparable data are available are ranked in Figure 7 by the s h a re of public funding in total health expenditures. Public funding is either by central (Federal), State (provincial/regional) and local government, or by social security plans. Countries with primarily government-funded (tax-based) systems are the Scandinavian countries, Ireland, New Zealand, and the United Kingdom. Public funding through social security plans is dominant in Austria, France, Germ a n y, Japan, and Switzerland. Examples of mixed systems with predominant public funding are Belgium, Spain, Italy, and Portugal. These systems are somewhere between the prototypes of social insurance and tax-based national health services.
Percent of Expenditures
There were only 5 of the sample of 20 OECD countries in 1997 with a public share of health care funding of less than t w o -t h i rds of total spending: Gre e c e , Korea, Mexico, Portugal, and the United States. Korea has the lowest public share of all OECD countries, followed closely by the United States (Table 6) . A further analysis of the structure of private financing in these countries, however, reveals important differences: Private funding in the United States is mostly by private health insurance, whereas out-of-pocket payments are the most important source of private funding in Greece, Korea, and Portugal. This has important implications for health policy analysis of these countries. First, another warning on data quality is appropriate: The collection of the data in Table 6 has only recently been undertaken by the OECD Secretariat. Good estimates of out-of-pocket payments, in particular, are difficult to obtain. Greece and Korea, for example, revised their estimates substantially upward in OECD Health Data 99 (Organization for Economic Cooperation and Development, 1999b), which also lead to a marked change in their estimates of total spending. Second, the notion of the public-private mix used in the analysis presented in this article is based on the concept of direct sources of payment, attempting to ascertain who actually pays (the consumer or a third party).
It should be noted that this analysis in terms of gross financing leads to a potentially distorted picture for countries such as the United States, which has an elaborate system of tax incentives for private insurance. An alternative concept of "net social expenditure" has therefore been developed by the OECD Secretariat, which takes the redistributive effects of tax deductions into account. terms of net social spending is smaller than in terms of gross social spending (Adema 1999) .
SHIFTING PUBLIC-PRIVATE MIX
Health expenditures are among the most dynamic components of private consumption in a majority of OECD countries. With gro wing wealth, households tend to put more health care goods into their "shopping basket," such as new (and traditional) dru g s , a l t e rnative medicine, and first class accommodations when they are inpatients (often financed by complementary insurance). Relatively wealthy pensioners add to this private health care expenditure with their outof-pocket payments (Figure 8) .
At the same time, public insurance plans have increased their rates of copayment and cost sharing in general. As a result, out-of-pocket payments as a share of total health care funding have increased in a majority of OECD countries for which comparable data are available (Table 7) .
Countries differ substantially, however, with respect to the fundamental role of and trend in out-of-pocket payments: In some countries, copayments tend to decrease relative to overall spending as countries increase the coverage of the population by public plans and other third-party-payment arrangements. Other countries with universal coverage seem to put an increasing burden of copayment on their patients, partly in an attempt to contain costs under public plans.
With the available data, however, it is difficult to separate this induced private spending from other structural changes, such as increased "luxury" spending on health care. Some evidence about a possible link between cost-containment measures under public plans and the relative growth of private health care spending is provided in Figure 8 . Total social spending is mainly the sum of: health care, sickness cash benefits, old age cash benefits, survivors', family, disability, housing and unemployment assistance, and active labor market policy Organization for Economic Cooperation and Development, 1999b. Figure 8 shows that there is some association between growth of private spending as part of total spending on health and the g rowth of public spending within total socialspending. In the majority of the countries studied in Figure 8 , public expenditure on health decreased as part of total social spending, while at the same time, a growing part of health care was paid for by private sources (mainly out-of-pocket payment and private insurance).
TRENDS IN SERVICE DELIVERY AND SPENDING
Health care re f o rms in many OECD countries over a decade or more have resulted in shifts both in the public-private mix of financ- ing and in the division of labor among levels of care (primary, secondary, tert i a ry). Ta b l e 8 provides an overview of transformation in health sectors in OECD countries. Since 1980, there has been a shift toward p r i m a ry care and away from specialist care in Australia, Austria, Finland, France, Iceland, the Netherlands, and the United States. This reflects, in part, cost-containment eff o rts: There is evidence that overall health care spending is lower when the ratio of primary care spending to total spending is higher (Organization for Economic Cooperation and Development, 1995) .
In the United States, the proportion of total health care spending devoted to inpatient care declined by 7.2 perc e n t a g e points between 1980 and 1997, while the proportion of resources channeled to outpatient care increased by 5 percentage points. This is likely to have been, in part, a result of the shift toward managed care. The proportion of total spending devoted to pharmaceuticals has increased in most OECD countries over the same period. However, although the United States has high absolute pharmaceutical spending per capita, it continues to allocate one of (Norway, 1990; New Zealand, 1992; Spain, 1993; Greece, 1994; Portugal, Switzerland, and United Kingdom, 1995; Australia, Austria, Germany, Ireland, Japan, and Luxembourg, 1996) . Total expenditure on health includes public and private spending.Only major sectors are shown, thus percentages do not add to 100.OECD and European Union averages include countries where data are a vailable for selected years.
the smallest proportions of total health care spending to pharmaceuticals (10 percent in 1997).
It is difficult to assess from the available international data sets to what degree the emerging consensus of the public health movement has resulted in a shift of resources toward a relative increase in spending on preventive services. This is certainly an area of international health statistics where more work is needed.
Other questions that are difficult to answer include: Do costs of public health administration and private health insurance incre a s e faster than personal health care services and medical goods? Are administrative costs in the United States higher relative to other countries? Is there a tendency toward everi n c reasing shares of administrative costs? The evidence from the available data in OECD Health Data 99 ( O rganization for Economic Cooperation and Development, 1999b ) is inconclusive at the moment.
There seems to be, however, some evidence that expenditures on health re s e a rch and development grow faster than personal ser vices, in part i c u l a r research and development of the pharmaceutical industry. There remain at the same time open questions about the statistics and health-policy reasons for a smaller reported share of investment into health care facilities in many OECD countries in the 1990s compared with the 1970s.
REVISIONS OF HEALTH EXPENDI-TURE ESTIMATES
Those working on international comparisons of health expenditure estimates continue to wrestle with four main obstacles to international comparability:
• Differences in the way the boundaries are drawn in countries between health care and other social care, in particular regarding care for the disabled and for frail elderly persons.
• Information gaps in and underestimation of private expenditure on health.
• Lack of international standards for the functional and industrial classification of health expenditures in health accounts.
• Lack of standardization in health accounting methodology with national accounting methodology, which provides the universally accepted toolbox for classifying other economic statistics. These obstacles are generally re c o gnized by those working on international comparisons. However, progress in raising standards has been rather slow over the years because of the limited resources invested in this difficult area both in many countries and by international initiatives.
The evolution of the OECD health accounts has resulted in improved and better harmonized data over the last 3 years. A list of examples follows:
• OECD estimates for Denmark and Sweden have been revised at the boundary between health and social care.
• Greece and Korea have revised their estimates of private health expenditures; • Canada has recently revisited the publicprivate mix in health care (Canadian Institute for Health Information, 1999 ).
• G e rmany and France are curre n t l y adding more detail to the functional breakdown in health accounts. • Other countries have strengthened the links between their national health accounts (NHA) and other economic and social statistics (e.g., Austria and the United States) or have projects underway for doing so (e.g., Australia and the United Kingdom). Many more countries are curre n t l y revisiting their NHA, considering health accounts, or starting to design a NHA project (notably the Czech Republic, Hungary, and Poland).
